Adult-onset Still's disease epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD). In the Japanese and the European populations, the reported prevalence rates range from 10 to 340 cases per 100,000 individuals. The disease occurs worldwide and usually affects young adults (age 16-35 years). Adult-onset Still's disease (AOSD) affects females more than males. Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals. | There is a dearth of data regarding the [[incidence]] and [[prevalence]] of adult-onset Still's disease (AOSD). In the Japanese and the European populations, the reported [[prevalence]] rates range from 10 to 340 cases per 100,000 individuals. The disease occurs worldwide and usually affects young adults (age 16-35 years). Adult-onset Still's disease (AOSD) affects females more than males. Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher [[mortality rate]] compared to younger individuals. | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence and prevalence=== | ===Incidence and prevalence=== | ||
* There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD). | * There is a dearth of data regarding the [[incidence]] and [[prevalence]] of adult-onset Still's disease (AOSD). | ||
* In the Japanese and the European populations, the reported prevalence rates range from 10 to 340 cases per 100,000 individuals.<ref name="urlAdult-onset Stills disease - ScienceDirect">{{cite web |url=https://www.sciencedirect.com/science/article/pii/S1568997214000986#bb0050 |title=Adult-onset Still's disease - ScienceDirect |format= |work= |accessdate=}}</ref> | * In the Japanese and the European populations, the reported [[prevalence]] rates range from 10 to 340 cases per 100,000 individuals.<ref name="urlAdult-onset Stills disease - ScienceDirect">{{cite web |url=https://www.sciencedirect.com/science/article/pii/S1568997214000986#bb0050 |title=Adult-onset Still's disease - ScienceDirect |format= |work= |accessdate=}}</ref> | ||
* The disease occurs worldwide and usually affects young adults (age 16-35 years). | * The disease occurs worldwide and usually affects young adults (age 16-35 years). | ||
* In France, the annual incidence of AOSD was estimated to be 0.16 per 100,000 individuals.<ref name="pmid7668903">{{cite journal |vauthors=Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A |title=Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France |journal=Ann. Rheum. Dis. |volume=54 |issue=7 |pages=587–90 |date=July 1995 |pmid=7668903 |pmc=1009940 |doi= |url=}}</ref> | * In France, the annual [[incidence]] of AOSD was estimated to be 0.16 per 100,000 individuals.<ref name="pmid7668903">{{cite journal |vauthors=Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A |title=Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France |journal=Ann. Rheum. Dis. |volume=54 |issue=7 |pages=587–90 |date=July 1995 |pmid=7668903 |pmc=1009940 |doi= |url=}}</ref> | ||
* In Japan, the annual incidence of AOSD was estimated to be 0.22 per 100,000 individuals.<ref name="pmid9465547">{{cite journal |vauthors=Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R, Kojima M, Lin Y, Hashimoto S, Inaba Y, Minowa M, Aizawa S, Ichikawa Y, Miyasaka N |title=Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan |journal=J Epidemiol |volume=7 |issue=4 |pages=221–5 |date=December 1997 |pmid=9465547 |doi= |url=}}</ref> | * In Japan, the annual [[incidence]] of AOSD was estimated to be 0.22 per 100,000 individuals.<ref name="pmid9465547">{{cite journal |vauthors=Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R, Kojima M, Lin Y, Hashimoto S, Inaba Y, Minowa M, Aizawa S, Ichikawa Y, Miyasaka N |title=Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan |journal=J Epidemiol |volume=7 |issue=4 |pages=221–5 |date=December 1997 |pmid=9465547 |doi= |url=}}</ref> | ||
* In Norway, the annual incidence of AOSD was estimated to be 0.4 per 100,000 individuals.<ref name="pmid16467042">{{cite journal |vauthors=Evensen KJ, Nossent HC |title=Epidemiology and outcome of adult-onset Still's disease in Northern Norway |journal=Scand. J. Rheumatol. |volume=35 |issue=1 |pages=48–51 |date=2006 |pmid=16467042 |doi=10.1080/03009740510026616 |url=}}</ref> | * In Norway, the annual [[incidence]] of AOSD was estimated to be 0.4 per 100,000 individuals.<ref name="pmid16467042">{{cite journal |vauthors=Evensen KJ, Nossent HC |title=Epidemiology and outcome of adult-onset Still's disease in Northern Norway |journal=Scand. J. Rheumatol. |volume=35 |issue=1 |pages=48–51 |date=2006 |pmid=16467042 |doi=10.1080/03009740510026616 |url=}}</ref> | ||
===Age=== | ===Age=== | ||
* Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref> | * Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher [[mortality rate]] compared to younger individuals.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref> | ||
=== Gender === | === Gender === |
Latest revision as of 13:22, 23 April 2018
Adult-onset Still's disease |
Differentiating Adult-onset Still’s Disease from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Template:Adult-onset Still's disease On the Web |
American Roentgen Ray Society Images of Template:Adult-onset Still's disease |
FDA on Adult-onset Still's disease epidemiology and demographics |
Template:Adult-onset Still's disease in the news |
Risk calculators and risk factors for Template:Adult-onset Still's disease |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]
Overview
There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD). In the Japanese and the European populations, the reported prevalence rates range from 10 to 340 cases per 100,000 individuals. The disease occurs worldwide and usually affects young adults (age 16-35 years). Adult-onset Still's disease (AOSD) affects females more than males. Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals.
Epidemiology and Demographics
Incidence and prevalence
- There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD).
- In the Japanese and the European populations, the reported prevalence rates range from 10 to 340 cases per 100,000 individuals.[1]
- The disease occurs worldwide and usually affects young adults (age 16-35 years).
- In France, the annual incidence of AOSD was estimated to be 0.16 per 100,000 individuals.[2]
- In Japan, the annual incidence of AOSD was estimated to be 0.22 per 100,000 individuals.[3]
- In Norway, the annual incidence of AOSD was estimated to be 0.4 per 100,000 individuals.[4]
Age
- Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals.[5]
Gender
Race
- Adult-onset Still's disease (AOSD) affects Caucasians more than other races.[8]
References
- ↑ "Adult-onset Still's disease - ScienceDirect".
- ↑ Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A (July 1995). "Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France". Ann. Rheum. Dis. 54 (7): 587–90. PMC 1009940. PMID 7668903.
- ↑ Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R, Kojima M, Lin Y, Hashimoto S, Inaba Y, Minowa M, Aizawa S, Ichikawa Y, Miyasaka N (December 1997). "Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan". J Epidemiol. 7 (4): 221–5. PMID 9465547.
- ↑ Evensen KJ, Nossent HC (2006). "Epidemiology and outcome of adult-onset Still's disease in Northern Norway". Scand. J. Rheumatol. 35 (1): 48–51. doi:10.1080/03009740510026616. PMID 16467042.
- ↑ "Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts".
- ↑ "Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts".
- ↑ "A controlled study of the long-term prognosis of adult still's disease - ScienceDirect".
- ↑ "Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts".